| Financial Year |
March 31 2023 |
| Monetary Funds |
111,738,569.76 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
88,025,093.61 |
| Advances to Suppliers |
75,302,034.39 |
| Other Receivables |
4,505,167.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
474,538,780.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,841,601.25 |
| Total Current Assets |
770,951,246.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
484,003,066.07 |
| Investment Properties |
-- |
| Fixed Assetes |
1,452,288,765.37 |
| Under-construction Projects |
52,246,753.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,261,412.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,999,691.43 |
| Deferred Income Tax Assets |
26,476,982.29 |
| Other Non-Current Assets |
4,632,898.07 |
| Sub-Total of Non-Current Assets |
2,114,976,792.44 |
| Total Assets |
2,885,928,039.18 |
| Short-Term Loans |
128,141,496.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
169,838,946.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,298,202.78 |
| Taxes Payable |
13,629,387.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,909,715.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,232,246.31 |
| Other Current Liabilities |
2,090,650.74 |
| Sub-Total of Current Liabilities |
430,409,560.41 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
53,150,282.26 |
| Other Non-Current Liabilities |
5,241,894.69 |
| Sub-Total of Non-Current Liabilities |
121,531,243.37 |
| Total Liabilities |
551,940,803.78 |
| Paid-In Capital(Or Share Stock) |
1,152,000,200.00 |
| Capital Surplus |
231,293,258.91 |
| Surplus Reserve |
156,010,059.78 |
| LESS:Treasury Stock |
201,001,825.50 |
| Undistributed Profits |
708,115,402.39 |
| Minority Stockholder's Interest |
-3,311,181.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,337,298,416.66 |
| Owner's Equity（Stockholder's Equity） |
2,333,987,235.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,885,928,039.18 |
